Quick Answer
Axsome Therapeutics, Inc. reported Net Income of -$183.17 million for fiscal year 2025.
Axsome Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$183.17M | +36.2% |
| 2024 | -$287.22M | -20.1% |
| 2023 | -$239.24M | -27.8% |
| 2022 | -$187.13M | -43.5% |
| 2021 | -$130.40M | -26.7% |
| 2020 | -$102.90M | -50.6% |
| 2019 | -$68.35M | -120.7% |
| 2018 | -$30.97M | -7.0% |
| 2017 | -$28.94M | -6.4% |
| 2016 | -$27.20M | -122.8% |
| 2015 | -$12.21M | -103.5% |
| 2014 | -$6.00M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$47.23M | +26.9% | +1.6% |
| June 30, 2025 | -$47.97M | +39.5% | +19.3% |
| March 31, 2025 | -$59.41M | +13.1% | +8.0% |
| September 30, 2024 | -$64.60M | -3.9% | +18.6% |
| June 30, 2024 | -$79.34M | -18.1% | -16.1% |
| March 31, 2024 | -$68.36M | -509.4% | -9.9% |
| September 30, 2023 | -$62.20M | -38.8% | +7.4% |
| June 30, 2023 | -$67.17M | -62.1% | -498.8% |
- Axsome Therapeutics, Inc. showed an increase of +36.2% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Axsome Therapeutics, Inc.’s net income has declined by 2952.6% (from -$6.00 million to -$183.17 million).
- The most recent figure is from Axsome Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: